Analyst firms · Capital One · KOD
Capital One KOD price target and rating history
Kodiak Sciences Inc (KOD) · Health Care
Capital One rates Kodiak Sciences Inc (KOD) Overweight with a $12 price target, as of its latest action on Nov 17, 2023. It has published 3 rating actions on KOD since November 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Overweight
- Price target
- $12
- Median target, all firms
- Too few
- Actions on KOD
- 3
Capital One price target on KOD
Every Capital One rating on KOD
- Nov 17, 2023
- Jul 24, 2023
- Nov 15, 2022
How other firms rate KOD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Goldman Sachs | Neutral | $36 | Sep 24, 2026 |
| Chardan Capital Markets | Buy | $61 | May 11, 2026 |
Questions about Capital One and KOD
- What is Capital One's price target for KOD?
- Capital One's latest stated price target for Kodiak Sciences Inc (KOD) is $12, from its action on Nov 17, 2023.
- What is Capital One's rating on KOD?
- Capital One rates KOD Overweight, a bullish rating, as of Nov 17, 2023.
- When did Capital One last change its view on KOD?
- On Nov 17, 2023, Capital One upgrades to Overweight from Equal Weight, price target $7 to $12.
More KOD rating histories
All Capital One ratingsKOD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.